Parabilis Medicines, Inc.
PBLS
$4B
Market cap
$4B
Stock Price
$39.35+$7.75 (+24.53%)
Aug 18, 2026
52W High $39.3552W Low $25.01
Company Details
Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment. The company develops stabilized helical peptide therapeutics through its Helicon disc...
IPO Date
—
Website
parabilismed.comQuarterly reports
Revenue & Profitability
Operating Cash Flow
CapEx Spend
CapEx Spend
OpEx vs Revenue Growth (YoY)
Stock-Based Compensation
OpEx Breakdown
War Chest
Shares Outstanding
Shares Outstanding
Revenue Per Employee
Revenue / Employee